scholarly journals Borderline Ovarian Tumor

2021 ◽  
Vol 5 (2) ◽  
pp. 261-266
Author(s):  
Gistin Husnul Khatimah ◽  
Andi Friadi

Ovarian borderline tumors are a group of pathologic tumors that exhibit a higher proliferative activity when compared to benign tumors. Due to the absence of a screening method, ovarian cancer is often diagnosed when the patient already has a complaint, or at an advanced stage. A 24-year-old patient was diagnosed with cystic ovarian neoplasm, the results of physical examination and support support the possibility of malignancy. In this patient, a left salphingo-oophorectomy was chosen instead of cystectomy, this was done considering the size of the tumor mass was large enough so that the normal tissue of the ovary was estimated to be almost absent. From the results of the PA laboratory is cystadenoma multiloculare ovarii mucinosum borderline with this microinvation. The patient found massive ascites which could be classified as high risk. In high-risk stage I borderline ovarian tumors, laparotomy should include hysterectomy and bilateral salpingo-oophorectomy. However, because the patient still expects reproductive function, conservative surgery can be performed by only performing unilateral salpingo-oophorectomy, omentum (left ovary and left tube), left inguinal gland and peritoneal rinses. Additional platinum-based chemotherapy such as carboplatine for 3-6 cycles may be indicated in high-risk patients such as this case. (left ovary and left tube) omentum, left inguinal gland and peritoneal rinses. Additional platinum-based chemotherapy such as carboplatine for 3-6 cycles may be indicated in high-risk patients such as this case. (left ovary and left tube) omentum, left inguinal gland and peritoneal rinses. Additional platinum-based chemotherapy such as carboplatine for 3-6 cycles may be indicated in high-risk patients such as this case.Keywords: Borderline ovarian tumor, conservative surgery

2005 ◽  
Vol 15 (4) ◽  
pp. 601-605 ◽  
Author(s):  
M. Shimada ◽  
J. Kigawa ◽  
Y. Kanamori ◽  
H. Itamochi ◽  
T. Oishi ◽  
...  

We conducted the present study to determine the outcome of patients with early ovarian cancer who underwent three courses of adjuvant chemotherapy after complete surgical staging. One hundred consecutive patients with stage I–II epithelial ovarian cancer who had undergone complete surgical staging and received three courses of platinum-based chemotherapy were entered in this study. Twenty-one patients were low risk, defined as stage IA–B, grade 1 and histologic types except for clear cell adenocarcinoma, and remaining 79 were high risk. All patients with stage IA or IB, whatever histologic type and histopathologic grade, were alive without disease. The 5-year survival rate was 89.4% for patients with stage IC and 76.2% for those with stage II. The 5-year survival rate for low- and high-risk patients was 100% and 89.4%, respectively. The survival rate for grade 1 was significantly better than that for grade 2 or 3. Multivariate analysis revealed that histologic grade was an independent prognostic factor in stage IC–II ovarian cancer. The outcome of patients with early ovarian cancer undergoing three courses of chemotherapy after complete surgical staging was favorable even in high-risk patients


2001 ◽  
Vol 120 (5) ◽  
pp. A376-A376
Author(s):  
B JEETSANDHU ◽  
R JAIN ◽  
J SINGH ◽  
M JAIN ◽  
J SHARMA ◽  
...  

2005 ◽  
Vol 173 (4S) ◽  
pp. 436-436
Author(s):  
Christopher J. Kane ◽  
Martha K. Terris ◽  
William J. Aronson ◽  
Joseph C. Presti ◽  
Christopher L. Amling ◽  
...  

2004 ◽  
Vol 171 (4S) ◽  
pp. 263-263
Author(s):  
Nathalie Rioux-Leclercq ◽  
Florence Jouan ◽  
Pascale Bellaud ◽  
Jacques-Philippe Moulinoux ◽  
Karim Bensalah ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document